EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.6.3.5 | Acute Kidney Injury |
23107895 |
Human renalase: a review of its biology, function, and implications for hypertension. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 4 3 3 |
1.6.3.5 | Acute Kidney Injury |
24762661 |
Renalase, a new secretory enzyme: Its role in hypertensive-ischemic cardiovascular diseases. |
causal interaction ongoing research therapeutic application unassigned |
1 4 1 0 |
1.6.3.5 | Acute Kidney Injury |
25461379 |
Renalase, kidney and cardiovascular disease: Are they related or just coincidentally associated? |
causal interaction ongoing research therapeutic application unassigned |
4 2 3 0 |
1.6.3.5 | Acute Kidney Injury |
25906147 |
Identification of a receptor for extracellular renalase. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 3 1 |
1.6.3.5 | Acute Kidney Injury |
27194994 |
Renalase and Biomarkers of Contrast-Induced Acute Kidney Injury. |
causal interaction diagnostic usage unassigned |
1 1 0 |
1.6.3.5 | Acute Kidney Injury |
27778420 |
Urinary renalase concentration in patients with preserved kidney function undergoing coronary angiography. |
causal interaction diagnostic usage ongoing research therapeutic application |
2 3 2 1 |
1.6.3.5 | Acute Kidney Injury |
30797821 |
Renalase attenuates mitochondrial fission in cisplatin-induced acute kidney injury via modulating sirtuin-3. |
causal interaction unassigned |
2 0 |
1.6.3.5 | Acute Kidney Injury |
32394908 |
Novel biomarkers of acute kidney injury following living donor liver transplantation. |
causal interaction diagnostic usage therapeutic application unassigned |
3 2 1 0 |
1.6.3.5 | Adenocarcinoma |
26972355 |
Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 4 4 |
1.6.3.5 | Albuminuria |
14694265 |
Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy. |
causal interaction therapeutic application unassigned |
3 2 0 |